Related Experiment Videos
Neuroblastoma cells for testing neuroprotective drug effects
1Institut für Pharmakologie und Toxikologie, Philipps-Universität Marburg, Marburg/Lahn, Germany.
Journal of Pharmacological Methods
|September 1, 1991
Summary
Neuroblastoma cells effectively model neuroprotective drug efficacy. Certain drugs protected these cells from hypoxic damage, showing promise for neurological research and treatment development.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Developing reliable in vitro models for neuroprotection is crucial for drug discovery.
- Neuroblastoma cells offer a potentially valuable cell line for studying neuronal damage and drug effects.
Purpose of the Study:
- To evaluate the suitability of neuroblastoma cells as a model for assessing neuroprotective drug effects.
- To identify drugs that protect against cytotoxic hypoxia-induced damage in neuroblastoma cells.
Main Methods:
- Cytotoxic hypoxia was induced in cultured neuroblastoma cells using sodium cyanide and glucose deprivation.
- Drug treatments were administered before, during, and after the hypoxic insult.
- Cellular damage, activity, and viability were assessed by measuring high-energy phosphates and protein content.
Main Results:
- Barbiturates and phenytoin exhibited neurotoxic effects at higher concentrations (>300 µmol/L).
- Chlorpromazine, dizocilpine, ketamine, ketazocine, naftidrofuryl, and flunarizine demonstrated significant neuroprotective properties.
- Results correlated well with experiments using primary neuron cultures and in vivo models.
Conclusions:
- Neuroblastoma cells serve as a suitable and reliable in vitro model for screening neuroprotective agents.
- This model system can predict drug efficacy observed in more complex biological systems.
- The findings support the use of neuroblastoma cells in preclinical neuroprotection research.